Trial · NCT03170271
Adverse events80
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 80
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Food poisoning | Gastrointestinal disorders | Benralizumab | 1 | 427 | 1 |
| serious | Food poisoning | Gastrointestinal disorders | Placebo | 0 | 229 | 0 |
| serious | Anti-neutrophil cytoplasmic antibody positive vasculitis | Immune system disorders | Benralizumab | 1 | 427 | 1 |
| serious | Anti-neutrophil cytoplasmic antibody positive vasculitis | Immune system disorders | Placebo | 0 | 229 | 0 |
| serious | Cytokine release syndrome | Immune system disorders | Benralizumab | 1 | 427 | 1 |
| serious | Cytokine release syndrome | Immune system disorders | Placebo | 0 | 229 | 0 |
| serious | Appendicitis | Infections and infestations | Benralizumab | 1 | 427 | 1 |
| serious | Appendicitis | Infections and infestations | Placebo | 0 | 229 | 0 |
| serious | Cellulitis | Infections and infestations | Benralizumab | 0 | 427 | 0 |
| serious | Cellulitis | Infections and infestations | Placebo | 1 | 229 | 1 |
| serious | Gastroenteritis | Infections and infestations | Benralizumab | 0 | 427 | 0 |
| serious | Gastroenteritis | Infections and infestations | Placebo | 1 | 229 | 1 |
| serious | Pneumonia | Infections and infestations | Benralizumab | 2 | 427 | 2 |
| serious | Pneumonia | Infections and infestations | Placebo | 2 | 229 | 2 |
| serious | Respiratory tract infection | Infections and infestations | Benralizumab | 0 | 427 | 0 |
| serious | Respiratory tract infection | Infections and infestations | Placebo | 1 | 229 | 1 |
| serious | Urinary tract infection | Infections and infestations | Benralizumab | 0 | 427 | 0 |
| serious | Urinary tract infection | Infections and infestations | Placebo | 1 | 229 | 1 |
| serious | Contusion | Injury, poisoning and procedural complications | Benralizumab | 1 | 427 | 1 |
| serious | Contusion | Injury, poisoning and procedural complications | Placebo | 0 | 229 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03170271/events?page=2